Identity

Clopidol is an active therapeutic chemical synthetic medicine used within the poultry sector to target specific parasitic infections.

Overview

Clopidol is a high-priority therapeutic anticoccidial used in the Indian poultry industry. As a synthetic pyridinol coccidiostat, it is specifically indicated for the prevention of Coccidiosis, targeting the early development of Eimeria sporozoites. To ensure compliance with food safety and regulatory standards, its administration requires a statutory withdrawal period of 5 days. Its mode of action is purely coccidiostatic.

Structured Facts

Indications

Coccidiosis, Eimeria species (early sporozoite stage).

Mechanism of Action

Reversibly inhibits mitochondrial energy production in the parasite by blocking electron transport, likely targeting the cytochrome b complex.

Dosage

125 g/ton in complete feed.

Administration Route

Feed.

Withdrawal Period

5 Days (India); 0 Days (US/FDA).

Contraindications

Not specified in sources (non-target carryover limits apply to laying birds).

Adverse Effects

Because its action is static, withdrawing the drug too early in the cycle allows dormant sporozoites to resume development, resulting in a rebound clinical outbreak.

Quantitative Data

• Dose: 125 g/ton
• Withdrawal: 5 Days

Relationships

• Target Diseases: Coccidiosis (Eimeria species).
• Related Medicines: Synergistic with methyl benzoquate (a quinolone coccidiostat).